- CMS finalizes 2.3% hospital pay bump, mandatory joint replacement model: 9 things to know
- How ambulatory shifts are reshaping perioperative strategy
- Cyclosporiasis cases top 18,000: 3 updates
- How Allegheny Health Network Strengthened its Foundation for IV Compounding Safety with Automation and Standardization¹
- Health plan customer service reps have AI in their ear
- Centene’s buyouts could have a $315M+ price tag for the rest of the year
- Medicare pay cut sparks specialty battle over skin cancer care
- Cardiovascular Institute of New England provides notice of data incident
- CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date
- Why autonomy — not just capital — is winning over cardiologists
- The $36 vs. $95 problem: How RVU negotiations are skewing physician pay
- Mississippi hospital board member, former CEO remembered as advocate for rural communities
- Pennsylvania SUD treatment locator reaches 146K users
- Top 10 dental, DSO stories in July
- Ohio youth treatment facility faces scrutiny over reported abuse: 8 notes
- What dental leaders told us in July
- Urban hospital closures and net change, by state
- Nebraska launches dashboard tracking rural health funds
- ADSO sues Colorado Dental Board over practice ownership rule
- New patient acquisition is the top growth driver for dental practices: Report
- 20 new behavioral health projects to know
- Nurses, patients protest North Star Health Alliance ASC closure
- No Surprises Act under attack by payers: 8 things to know
- Dental staffing wages up 23% since 2021: ADA
- AtlantiCare appoints anesthesiology, gastroenterology physician leaders
- Consumer dental spending up 24% over 10 years: 5 stats to know
- Baylor Scott & White joint venture expands outpatient behavioral health services
- 5 DSOs making headlines
- VA to explore GLP-1 treatment for alcohol use disorder: 4 notes
- A $5B wave of M&A hits the ASC industry
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- 145 physician medical groups led all healthcare M&A sectors in Q1
- 10 new ASCs in July
- Healthcare exec, telemedicine company owner sentenced for $35M DME fraud scheme
- Amylyx demystifies post-bariatric hypoglycemia with patient education website
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- A look at employers' attitudes toward ICHRAs
- Revised 340B Rebate Model Pilot Program moves forward, despite provider pushback
- Function Health lands $450M in growth financing to scale tech-enabled preventive health
- Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
- AbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market
- Op-ed: Hospitals on the edge, a time for CMS to do no harm
- Daily Routine Key To Good Health, Study Says
- Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook
- Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis
- Psilocybin Therapy Helps Ease Veterans' Severe PTSD, Pilot Study Finds
- Newsom Reverses On Long-Sought Paid Leave Benefit For California Teachers
- Nicotine Levels Are Rising Among Teens Who Vape, New Study Warns
- They Worked To Protect Public Health. Now They Want the Public’s Votes.
- The Newest Federally Recognized Tribe Wants Better Healthcare. It May Be On Its Own.
- 27 new behavioral health study findings to know
- 21 state behavioral health policy updates
- What will fuel the next wave of DSO growth
- Dentists’ biggest staffing headaches
- Maine increases dental deep sedation, anesthesia reimbursement rates
- Shionogi makes the call on COVID pill Xocova TV spot
- Psilocybin-assisted therapy reduced PTSD symptoms: 3 notes
- Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod
- Psychedelics, peptides and GLP-1s
- How 'physician-led' care team models tackle primary care's workforce problem
- How 7 systems divert behavioral health patients from the ED
- WellSpan Health, Hippocratic AI ink ‘multi-year’ partnership with plans to co-develop clinical AI agents
- Kaiser faces complaint over automated behavioral health triage system
- Free research hub Nila aims to demystify menopause, other hormone conditions
- Scientists Defend Fauci's Pandemic Work As Senate Hearing Turns Bitter
- Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
- Study Questions Effectiveness of Antihistamines in Easing Eczema
- Vaping Is Likely Reshaping The Future Of Cancer In The US, Study Argues
- Weekly Rundown: Counsel Health rolls out white label AI care platform; Community Health Network launches MyChart AI assistant
- New CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat
- Alnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026
- Waystar boosts 2026 outlook as AI-powered RCM solutions gain traction with providers
- YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
- Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
- Sugar Consumption Early In Life Linked To Increased Dementia Risk, World War II-Era Data Show
- Work Stress Harming Middle-Age Sleep, Study Says
- RFK Jr.'s Gardasil litigation ties subject to fresh lawmaker scrutiny after Merck settlement
- Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
- Hospice's Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Cell Phone Ownership Linked To Lower Reading Skills In Elementary Students
- Listen to the Latest ‘KFF Health News Minute’
- Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
- Medicaid Insurers’ Contracts on the Line in Tight Governor’s Race
- Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shift
- Cigna CEO: Express Scripts seeing 'significant early interest' from clients for new rebate-free PBM model
- Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
- Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
- FTC sues Hims & Hers over data privacy, billing practices
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Case Western Reserve University launches next-generation healthcare leadership program
- Lilly, Resilience commit $750M to boost US diabetes, obesity med production
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- Stellarus launches AI-powered health plan customer service representative copilot
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- Federal Loan Caps Add Barriers — And Likely Debt — for Healthcare Students
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Senate HELP committee advances nominees for CDC director, HHS preparedness head
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
Michigan healthcare freedom community forum
Aside from the state dispensing drugs under the first bill, this agenda looks remarkably like deregulation.
The devil will be in the details of bill language and changes made during passage.
Wednesday, October 2, 2024 12:30 p.m.
AGENDA
SB 542 Sen. Hertel Health; pharmaceuticals; choice of formulation, dosage, and route of administration for opioid antagonists by certain persons and governmental entities if department of health and human services distributes opioid antagonists free of charge; allow.
SB 668 Sen. Hertel Health occupations; physical therapists; prescription requirement for physical therapy treatment; eliminate, and make other modifications to the practice of physical therapy.
And any other business properly before the committee.
SB 542 Background:
Traditionally, there are two ways to get medications: some are over the counter (OTC), others require a prescription (Rx).
Michigan legislators created a third way about a year ago. For certain prescription drugs, they removed the need for a personal clinician. Instead, the state's MDHHS Medical Director writes a blanket Rx/ standing order for all pharmacies, directing them to dispense certain drugs (EMS opioid reversal drugs, for example).
Around the same time, the FDA removed the prescription requirement for Narcan. The cheapest, most common opioid reversing drug (Narcan) has been available over the counter ever since.
Michigan's response was problematic. Instead of allowing the public to go buy OTC Narcan for themselves, family, friends, or emergencies, the state racked up massive orders of Narcan to stock state police, schools, libraries, bars, and more institutions who might, one day, see a person with a drug overdose.
Predictably, massive demand raised prices and created shortages for those with real-life need.
Now, the state is doubling down.
More accurately, the state is using the legislative process to double down and increase the MDHHS role as drug distributor.
Questions we should ask:
- Why is the state expanding into the pharmacy space?
- Instead, shouldn't we make sure MDHHS is performing its core mission well?
The Senate Fiscal Agency (SFA) captures the facts of this bill.
https://legislature.mi.gov/documents/2023-2024/billanalysis/Senate/pdf/2023-SFA-0542-F.pdf
CONTENT
The bill would enact a new law to allow a person or governmental entity that was distributed an opioid antagonist by the Department of Health and Human Services (DHHS) at no cost to choose the formulation, type of delivery device, method of administration, or dosage of the opioid antagonist that the person or agency received; however, the bill specifies that the ability to choose the formulation or dosage of an opioid antagonist would not apply if that formulation or dosage choice jeopardized the DHHS's receipt of Federal funding.
"Opioid antagonist" would mean naloxone hydrochloride or any other similarly acting and equally safe drug approved by the United States Food and Drug Administration for the treatment of drug overdose.
BRIEF RATIONALE
The bill would give the individuals fighting the opioid crisis a choice about how best to administer opioid antagonists. According to testimony, opioids are the cause of 80% of drug deaths in Michigan and were responsible for the deaths of 3,000 Michigan residents in 2023.
Testimony also indicates that the Centers for Disease Control found that 40% of opioid overdoses occur in the presence of another individual. The ability to request a specific opioid antagonist formulation, device, dosage, or administration method could make the use of an opioid antagonist more successful in the event of an overdose, saving more lives.FISCAL IMPACT
The bill would have an indeterminate negative fiscal impact on the DHHS and no fiscal impact on local units of government. Currently, the DHHS operates a naloxone portal that provides intranasal and injectable naloxone to health organizations, community organizations, schools, bars and nightclubs, law enforcement, and other relevant agencies at no cost. The bill would expand the type of opioid antagonists available through the naloxone portal by allowing the receiving entity to choose the formulation, type of delivery device, method of administration, or dosage of the opioid antagonist. This would increase costs for the DHHS by potentially increasing the number of opioid antagonists distributed but could also increase costs through the distribution of more costly opioid antagonists. Additionally, the DHHS would face an increased administrative burden by increasing the complexity of requests.
Date Completed: 10-3-24
Each bill typically gets two hearings.
The PT bill is up again this week, along with a few more. The added bills bring new mental health mandates to hospitals, courts, and clinicians.
NAVIGATION NOTE: by scrolling up to the MI Senate - Health Policy tab in the Forum, you can find links to look up bills, committee live video feed, and hearing archives.
Wednesday, October 9, 2024 12:30 p.m.
AGENDA
SB 668 Sen. Hertel Health occupations; physical therapists; prescription requirement for physical therapy treatment; eliminate, and make other modifications to the practice of physical therapy.
SB 915 Sen. Hertel Mental health; hospitalization; person requiring treatment; revise, and modify certain procedures for treatment.
SB 916 Sen. Santana Criminal procedure; mental capacity; outpatient treatment for misdemeanor offenders with mental health issues; provide for.
SB 917 Sen. Irwin Mental health; other; hospital evaluations for assisted outpatient treatment; expand.
SB 918 Sen. Wojno Mental health; other; petition for access to assisted outpatient treatment; expand to additional health providers.
And any other business properly before the committee.
According to the Michigan Legislature, Senate Bill 668 passed in the Senate on 10/23 and is moving to the House of Representatives.
https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0668
This Bill, as well as legally defining the entity of a physical therapist or a physical therapist assistant, alters the wording of legislation regarding the practice of physical therapy to to be focused upon referrals as opposed to prescriptions.
As opposed to a physical therapist receiving a prescription from another health care professional requesting physical therapy for their patient, the legislation now states that they receive referrals. This referral focused language is supposed to place more volition on the part of the physical therapist. According to the bill summary, it is increasing the scope of practice of the physical therapist to, "include examining, evaluating, and testing an individual with a mechanical, physiological, or developmental impairment, a functional limitation, or a disability or other health movement-related condition to determine the cause of the physical therapy problem to be treated."
What should be considered very carefully is how this will effect the amount of paperwork that a physical therapist has to complete on a given day. My mother is a physical therapist, and I too often can think of times where she comes home after a 12 hour day only to complete several more hours of paperwork referred to colloquially among the therapists as "evals". Evaluations of new patients and entering them into the extensive online hospital system is time consuming and draining. We should think extensively about the possible effects of possibly adding more onto the plate of these therapists, especially during the patient referral or evaluation process.
(1) If a physical therapist who is treating a patient upon on the receipt of a referral from a health care professional, as described in section 17820 the physical therapist shall do all of the following, as applicable:
(a) Refer the patient back to the health care professional who made the referral for treatment if the physical therapist has reasonable cause to believe that symptoms or conditions are present that require services beyond the scope of practice of physical therapy.
(b) Consult with the health care professional who made the referral for treatment if the patient does not show reasonable response to treatment in a time period consistent with the standards of practice as determined by the board.(2) If a physical therapist who is treating a patient without a referral from a health care professional, under the conditions authorized in section 17820, the physical therapist shall do all of the following, as applicable:
(a) Refer the patient to an appropriate health care professional for treatment if the physical therapist has reasonable cause to believe that symptoms or conditions are present that require services beyond the scope of practice of physical therapy.
(b) Consult with an appropriate health care professional if the patient does not show reasonable response to treatment in a time period consistent with the standards of practice as determined by the board.
https://www.legislature.mi.gov/documents/2023-2024/billengrossed/Senate/pdf/2023-SEBS-0668.pdf
MDHHS's Assisted Outpatient Treatment (AOT) is a court-ordered program for individuals suffering from serious mental illness to participate in outpatient mental health treatment for a period of time. This program is intended to help people cope with their illness before it progresses to the point of hospitalization or incarceration. It is a court ordered program because these individuals may not willingly participate in various therapies. These court ordered therapies can include a variety of mandatory treatments, from therapy or case management to medication.
Michigan Senate Bills 915, 916, 917 and 918 all make amendments to this AOT program in a variety of ways:
https://legislature.mi.gov/documents/2023-2024/billanalysis/Senate/pdf/2023-SFA-0915-F.pdf
Senate Bill 915 (S-1) would amend Chapter 4 (Civil Admission and Discharge Procedures: Mental Illness) of the Mental Health Code to do the following:
-- Require a patient to be referred to a community mental health services program if a psychiatrist certified that the patient required assisted outpatient treatment (AOT).
-- Modify the type of health professional that could testify to a patient's need for AOT.
-- Modify the duration of second and third consecutive court orders for involuntary mental health treatment.
-- Allow a court, without a hearing, to convene a conference with an individual who was out of compliance with a court order for AOT and the individual's supervising agency to review compliance with the order.
-- Allow a peace officer to take an individual into protective custody for examination for mental health intervention if the officer had reasonable cause to believe the individual required treatment, instead of if the officer observed conduct that caused the officer to believe such.Senate Bill 916 (S-1) would amend the Mental Health Code to do the following:
-- Allow a physician, psychologist, or qualified health professional who had personally examined an individual to testify that that individual needed AOT.
-- Allow a prosecuting attorney, defendant, or defense counsel to bring a motion for an assessment to determine if a defendant met the criteria for misdemeanor diversion to AOT at the time a misdemeanor was charged, or any later time before trial.
-- Require a petition for diversion to AOT to be dismissed upon objection by a prosecuting attorney or defendant.
-- Allow a court to enter an order for diversion to AOT for up to 180 days.
-- Allow a court to modify a diversion to AOT, such as by diverting to inpatient hospitalization, if a defendant failed to comply with the AOT.
-- Require misdemeanor charges to remain pending upon diversion to AOT and to be dismissed as a condition of release from AOT.Senate Bill 917 (S-1) would amend the Mental Health Code to allow an individual who filed a petition asserting that another individual required mental health treatment to request and access mediation to resolve a dispute between the individual requiring treatment and the appropriate community mental health services program related to planning and providing services or support to the individual requiring treatment. In addition, if an individual were required by a court order to receive mental health services due to a petition, the bill would require a hospital to detain that individual for up to 24 hours.
Senate Bill 918 (S-1) would amend the Mental Health Code to allow a hospital director, agency, physician, psychologist, qualified mental health professional, or individual to file a petition for a second or continuing order of involuntary mental health treatment at least 14 days before the expiration of a current order of AOT if the individual receiving treatment were likely to refuse voluntary treatment and needed continued treatment.
The two bills which may prove problematic over time are bills 915 and 918. As SB915 reads on page 11, "If it comes to the attention of the court that an individual subject...is not complying with the order, that the assisted outpatient treatment has not been or will not be sufficient to prevent harm to the individual or to others, or that the individual believes that the assisted outpatient treatment program is not appropriate, the court may...without hearing...modify the order."
The court is able to relax the charge to outpatient therapy or heighten the charge to hospitalization at will, seemingly with any indication they may find. Having a more distinct communication system that requires a healthcare professional as a mediator between the courts and the patient may prove more robust in the long run.
SB918 is a short bill regarding who can file for the reapplication process of an unwilling person to this program. I found the wording a bit too broad. As the bill states on page 2, "a hospital director, an agency, a mental health professional supervising an individual's assisted outpatient treatment, or an individual 18 years of age or older may file a petition for a second or continuing order of involuntary mental health treatment if the individual continues to be a person requiring treatment and the individual is likely to refuse treatment on a voluntary basis when the order expires."
The inclusion of the word "agency" is particularly what I dislike about the bill. If a patient is in need of help and unwilling to participate in treatment, the request should come from a healthcare professional who cared for them or from a personal friend or family member who has their best interests in mind. When legislation like this decides who and who does not receive mandatory hospitalizations without hearing, agencies seem a bit too impersonal for that process.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























